We are live on ! Find out more
MP

MSD Partners Portfolio holdings

AUM $82.3M
1-Year Est. Return 15.13%
This Fund
S&P 500
This Quarter Est. Return
-7.98%
1 Year Est. Return
-15.13%
3 Year Est. Return
-8.08%
5 Year Est. Return
-28.09%
10 Year Est. Return
+16.55%
AUM
$745M
AUM Growth
-$79.3M
Cap. Flow
-$14.1M
Cap. Flow %
-1.9%
Top 10 Hldgs %
90.76%
Holding
34
New
8
Increased
1
Reduced
2
Closed
7

Top Sells

Rank Stock Value
1
PCG icon
PG&E
PCG
+$61.3M
2
RHT
Red Hat Inc
RHT
+$52.6M
3
AGN
Allergan plc
AGN
+$13.4M
4
BWXT icon
BWX Technologies
BWXT
+$10.2M
5
MRTN icon
Marten Transport
MRTN
+$4.99M

Sector Composition

Rank Sector Weight
1 Industrials 34.73%
2 Technology 17.33%
3 Healthcare 10.71%
4 Financials 7.86%
5 Energy 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IHRT icon
26
iHeartMedia
IHRT
$579M
$296K 0.04%
+19,704
New +$280K
NBRV
27
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$100K 0.01%
200
BWXT icon
28
BWX Technologies
BWXT
$15.7B
-196,542
Closed -$10.2M
FXI icon
29
CALL
iShares China Large-Cap ETF
FXI
$4.6B
-875,000
Closed -$37.4M
PCG icon
30
PG&E
PCG
$38.1B
-2,676,554
Closed -$61.3M
SHOP icon
31
CALL
Shopify
SHOP
$160B
-75,000
Closed -$2.25M
TSLA icon
32
CALL
Tesla
TSLA
$1.43T
-712,500
Closed -$10.6M
AGN
33
DELISTED
Allergan plc
AGN
-80,000
Closed -$13.4M
RHT
34
DELISTED
Red Hat Inc
RHT
-280,000
Closed -$52.6M

Similar funds

MSD Partners's Q3 2019 Portfolio in Review

As of Q3 2019, MSD Partners held 34 positions worth $745M, down 9.6% from $825M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

MSD Partners's Q3 2019 filing shows 8 new, 1 increased, 2 reduced and 7 closed positions. Its largest new stake was Vaccinex, Inc. Common Stock: 5,836 shares worth $8.79M. The largest sale was PG&E, an estimated $61.3M.

By sector, the portfolio is most concentrated in Industrials at 35% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.

  • MSD Partners's largest Q3 2019 buy was Vaccinex, Inc. Common Stock: 5,836 shares worth $8.79M.
  • MSD Partners added most to Alaunos Therapeutics in Q3 2019, an estimated $22M increase.
  • MSD Partners's biggest Q3 2019 reduction was Marten Transport, cutting an estimated $4.99M.
  • MSD Partners fully exited PG&E in Q3 2019, selling an estimated $61.3M.
  • MSD Partners's ten largest holdings make up 91% of its $745M portfolio in Q3 2019.
  • MSD Partners opened 8 new positions and closed 7 in Q3 2019.
  • MSD Partners's portfolio value fell 9.6% quarter-over-quarter to $745M.

Based on MSD Partners's 13F filing for Q3 2019, filed 14 Nov 2019.